tiprankstipranks
Advertisement
Advertisement
Jyong Biotech Reports Higher Assets but Deeper Shareholders’ Deficit in June 2025 Unaudited Results
PremiumCompany AnnouncementsJyong Biotech Reports Higher Assets but Deeper Shareholders’ Deficit in June 2025 Unaudited Results
7M ago
Jyong Biotech ‘not aware’ of any material information amid share price movement
Premium
The Fly
Jyong Biotech ‘not aware’ of any material information amid share price movement
8M ago
Jyong Biotech Ltd trading resumes
Premium
The Fly
Jyong Biotech Ltd trading resumes
8M ago
Jyong Biotech Ltd trading halted, volatility trading pause
PremiumThe FlyJyong Biotech Ltd trading halted, volatility trading pause
11M ago
Jyong Biotech Ltd trading resumes
Premium
The Fly
Jyong Biotech Ltd trading resumes
11M ago
Jyong Biotech completes patient enrollment in Phase II trial of MCS-8
Premium
The Fly
Jyong Biotech completes patient enrollment in Phase II trial of MCS-8
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100